Skip to main content
Top

Drugs

Issue 18/2019

Content (13 Articles)

Acknowledgement to Referees

  • Acknowledgement to Referees

Drug Development for Rare Paediatric Epilepsies: Current State and Future Directions

Stéphane Auvin, Andreja Avbersek, Thomas Bast, Catherine Chiron, Renzo Guerrini, Rafal M. Kaminski, Lieven Lagae, Pierandrea Muglia, J. Helen Cross

Once-Daily versus Twice-Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies

Somratai Vadcharavivad, Warangkana Saengram, Annop Phupradit, Nalinee Poolsup, Wiwat Chancharoenthana

Correction to: Once-Daily versus Twice Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies

Somratai Vadcharavivad, Warangkana Saengram, Annop Phupradit, Nalinee Poolsup, Wiwat Chancharoenthana

Sotagliflozin: A Review in Type 1 Diabetes

Emma D. Deeks

Lasmiditan: First Approval

Yvette N. Lamb

Brolucizumab: First Approval

Anthony Markham

Correction to: Dapagliflozin: A Review in Type 1 Diabetes

Julia Paik, Hannah A. Blair

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images